Recent News

• 06.11.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.03.2025 - Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
• 06.03.2025 - Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
• 06.02.2025 - Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
• 06.02.2025 - Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
• 05.27.2025 - Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
• 05.27.2025 - Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
• 05.14.2025 - The BofA Securities 2025 Health Care Conference
• 05.14.2025 - Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
• 05.14.2025 - Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Recent Filings

• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.06.2025 - 8-K Current report